FDA issues highest-level warning over medical kits due to infection risk

The U.S. Food and Drug Administration (FDA) has classified a recall involving certain Medline medical kits containing BD ChloraPrep applicators as a Class I recall, the agency’s most serious recall classification.

The classification, reported on October 13, 2026, highlights a potential infection risk associated with products used in medical settings.

A Class I recall means there is a reasonable probability that exposure to or use of an affected product could cause serious adverse health consequences or death.

The designation does not mean that deaths have necessarily occurred.

What Is the Problem?

The recall involves certain medical kits distributed by Medline that contain BD ChloraPrep applicators, which are commonly used to prepare and disinfect patients’ skin before medical procedures.

The concern involves potential contamination with a fungus identified as Aspergillus penicillioides.

Contaminated products used during medical procedures could create an infection risk, particularly for patients who are already medically vulnerable.

Skin preparation is an important step in preventing infections before injections, surgeries and other procedures. Any potential contamination of products intended for this purpose requires careful attention from healthcare facilities.

Why Did the FDA Issue Its Highest-Level Warning?

The FDA uses three recall classifications based on the potential health risks associated with affected products.

Class I is the most serious category and is reserved for situations in which using or being exposed to a product could result in serious injury or death.

In this case, the classification reflects the potential consequences of using contaminated medical supplies, rather than confirmation that patients have suffered those outcomes.

The underlying recall began before October 13. The latest development is the FDA’s classification of its severity.

Which Products Are Affected?

The recall does not involve every Medline medical kit or every BD ChloraPrep product.

According to the FDA, the affected Medline convenience kits contain specific lots of two BD products:

Product	Item number	Affected lot
ChloraPrep Clear 1 mL Single Sterile applicator	930480	4032183
FREPP Clear 1.5 mL applicator	930299	4073005

These applicators are included in certain medical convenience kits containing supplies used during surgical and other healthcare procedures.

The FDA provides a full list of affected kits in its official recall notice.

What Are the Possible Health Consequences?

According to the FDA, contamination could potentially lead to serious complications, including bloodstream infections, sepsis and surgical-site infections.

In severe cases, patients might require additional medical procedures, removal of an intravenous catheter or prolonged treatment with antifungal medications.

The FDA warns that serious illness or death is possible if contaminated products are used.

However, as of August 17, Medline had not reported any serious injuries or deaths associated with this issue, according to the agency’s published information.

What Should Hospitals and Healthcare Providers Do?

The FDA says healthcare facilities and distributors should immediately check their inventory for affected products.

Facilities are instructed to quarantine the identified kits and destroy the entire affected kit after completing the required response forms.

The updated instructions are significant because an earlier notification had allowed certain kits to remain in use after the affected applicator was removed. For the products covered by the latest notice, destroying the entire kit is now required.

Distributors must also inform customers who may have received the affected supplies.

Is This a New Recall?

The original manufacturer recall began earlier in 2026.

BD announced a nationwide recall of the affected applicators in June, and Medline subsequently notified customers about medical kits containing those products.

The FDA issued an early safety alert on August 24.

On October 13, the FDA officially updated its communication to classify the Medline recall as Class I, its highest risk category.

The classification is the new development, rather than a newly discovered recall involving different products.

How to Get More Information

Healthcare professionals, medical facilities and customers with questions can contact Medline at 866-359-1704 or [email protected].

The FDA also encourages healthcare professionals and consumers to report suspected medical-device problems through its MedWatch safety reporting program.

The warning underscores the importance of checking recalled medical supplies, particularly products used in procedures where contamination could expose vulnerable patients to serious infections.